Atlanta Area Health System Offers Clinical Trial for PSMA-positive mCRPC Prostate Cancer—Investigates Novartis’ PLUVICTO®

Northside Hospital Cancer Institute,  in pursuing its commitment to providing high-quality&nbsp;prostate cancer treatment options, now offers a breakthrough treatment for men with one of the advanced forms of the disease. Situated in the Atlanta region, this community regional cancer care and research institute brings the clinical research as a care option for prostate cancer patients. 
The Condition